Staphylococcus aureus: A pathogen with still unresolved issues

Infection, Genetics and Evolution

Volumn 21, Issue , 2014, Pages 510-514

  Rasigade, Jean Philippe ^a,b   Vandenesch, François ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Bacterial toxins; Gene expression regulation; Molecular epidemiology; MRSA; Staphylococcus aureus; Vaccine strategy

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL TOXIN; BACTERIAL VACCINE; VIRULENCE FACTOR;

DRUG EFFECTS; HUMAN; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATHOGENICITY; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; BACTERIAL VACCINES; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VIRULENCE FACTORS;

EID: 84893778159     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.08.018     Document Type: Article

References (74)

1. Batra R., Cooper B.S., Whiteley C., Patel A.K., Wyncoll D., Edgeworth J.D. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin. Infect. Dis. 2010, 50:210-217.
2. Beaume M., Hernandez D., Francois P., Schrenzel J. New approaches for functional genomic studies in staphylococci. Int. J. Med. Microbiol. 2010, 300:88-97.
3. Bode L.G., Kluytmans J.A., Wertheim H.F., Bogaers D., Vandenbroucke-Grauls C.M., Roosendaal R., Troelstra A., Box A.T., Voss A., Van Der Tweel I., Van Belkum A., Verbrugh H.A., Vos M.C. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 2010, 362:9-17.
4. Boucher H.W., Corey G.R. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 2008, 46(Suppl. 5):S344-349.
5. Centers for Disease Control and Prevention, 2005. Cases of HIV infection and AIDS in the United States, 2004. HIV/AIDS surveillance report vol. 16. Available at: (accessed 22.12.12). http://www.cdc.gov/hiv/surveillance/resources/reports/2004report/#4.
6. Chambers H.F. Community-associated MRSA-resistance and virulence converge. N. Engl. J. Med. 2005, 352:1485-1487.
7. Corvaglia A.R., Francois P., Hernandez D., Perron K., Linder P., Schrenzel J. A type III-like restriction endonuclease functions as a major barrier to horizontal gene transfer in clinical Staphylococcus aureus strains. Proc. Natl. Acad. Sci. USA 2010, 107:11954-11958.
8. Daum R.S., Spellberg B. Progress toward a Staphylococcus aureus vaccine. Clin. Infect. Dis. 2012, 54:560-567.
9. Day N.P., Moore C.E., Enright M.C., Berendt A.R., Smith J.M., Murphy M.F., Peacock S.J., Spratt B.G., Feil E.J. A link between virulence and ecological abundance in natural populations of Staphylococcus aureus. Science 2001, 292:114-116.
10. Day N.P., Moore C.E., Enright M.C., Berendt A.P., Smith J.M., Murphy M.F., Peacock S.J., Spratt B.G., Feil E.J. Retraction. Science 2002, 295:971.
11. Defrance T., Taillardet M., Genestier L. T cell-independent B cell memory. Curr. Opin. Immunol. 2011, 23:330-336.
12. Deurenberg R.H., Vink C., Kalenic S., Friedrich A.W., Bruggeman C.A., Stobberingh E.E. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 2007, 13:222-235.
13. Diep B.A., Carleton H.A., Chang R.F., Sensabaugh G.F., Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 2006, 193:1495-1503.
14. Diep B.A., Chan L., Tattevin P., Kajikawa O., Martin T.R., Basuino L., Mai T.T., Marbach H., Braughton K.R., Whitney A.R., Gardner D.J., Fan X., Tseng C.W., Liu G.Y., Badiou C., Etienne J., Lina G., Matthay M.A., Deleo F.R., Chambers H.F. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc. Natl. Acad. Sci. USA 2010, 107:5587-5592.
15. Dohin B., Gillet Y., Kohler R., Lina G., Vandenesch F., Vanhems P., Floret D., Etienne J. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr. Infect. Dis. J. 2007, 26:1042-1048.
16. Edgeworth J.D. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. J. Antimicrob. Chemother. 2011, 66(Suppl. 2):ii41-ii47.
17. Faden H., Lesse A.J., Trask J., Hill J.A., Hess D.J., Dryja D., Lee Y.H. Importance of colonization site in the current epidemic of staphylococcal skin abscesses. Pediatrics 2010, 125:e618-624.
18. Gillet Y., Issartel B., Vanhems P., Fournet J.C., Lina G., Bes M., Vandenesch F., Piemont Y., Brousse N., Floret D., Etienne J. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
19. Gillet Y., Dumitrescu O., Tristan A., Dauwalder O., Javouhey E., Floret D., Vandenesch F., Etienne J., Lina G. Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases. Int. J. Antimicrob. Agents 2011, 38:457-464.
20. Gonzalez B.E., Rueda A.M., Shelburne S.A., Musher D.M., Hamill R.J., Hulten K.G. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect. Control. Hosp. Epidemiol. 2006, 27:1051-1056.
21. Gupta S., Ferguson N., Anderson R. Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 1998, 280:912-915.
22. Harris S.R., Feil E.J., Holden M.T., Quail M.A., Nickerson E.K., Chantratita N., Gardete S., Tavares A., Day N., Lindsay J.A., Edgeworth J.D., De Lencastre H., Parkhill J., Peacock S.J., Bentley S.D. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010, 327:469-474.
23. Iwase T., Uehara Y., Shinji H., Tajima A., Seo H., Takada K., Agata T., Mizunoe Y. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 2010, 465:346-349.
24. Kaito C., Omae Y., Matsumoto Y., Nagata M., Yamaguchi H., Aoto T., Ito T., Hiramatsu K., Sekimizu K. A novel gene, fudoh, in the SCCmec region suppresses the colony spreading ability and virulence of Staphylococcus aureus. PLoS ONE 2008, 3:e3921.
25. Kaito C., Saito Y., Nagano G., Ikuo M., Omae Y., Hanada Y., Han X., Kuwahara-Arai K., Hishinuma T., Baba T., Ito T., Hiramatsu K., Sekimizu K. Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence. PLoS Pathog. 2011, 7:e1001267.
26. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., Harrison L.H., Lynfield R., Dumyati G., Townes J.M., Craig A.S., Zell E.R., Fosheim G.E., Mcdougal L.K., Carey R.B., Fridkin S.K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
27. Kluytmans J.A., Mouton J.W., Ijzerman E.P., Vandenbroucke-Grauls C.M., Maat A.W., Wagenvoort J.H., Verbrugh H.A. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J. Infect. Dis. 1995, 171:216-219.
28. Knight G.M., Budd E.L., Whitney L., Thornley A., Al-Ghusein H., Planche T., Lindsay J.A. Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time. J. Antimicrob. Chemother. 2012, 67:2514-2522.
29. Kobayashi S.D., Malachowa N., Whitney A.R., Braughton K.R., Gardner D.J., Long D., Bubeck Wardenburg J., Schneewind O., Otto M., Deleo F.R. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J. Infect. Dis. 2011, 204:937-941.
30. Kreiswirth B., Kornblum J., Arbeit R.D., Eisner W., Maslow J.N., Mcgeer A., Low D.E., Novick R.P. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 1993, 259:227-230.
31. Labandeira-Rey M., Couzon F., Boisset S., Brown E.L., Bes M., Benito Y., Barbu E.M., Vazquez V., Hook M., Etienne J., Vandenesch F., Bowden M.G. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007, 315:1130-1133.
32. Laurent F., Lelievre H., Cornu M., Vandenesch F., Carret G., Etienne J., Flandrois J.P. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J. Antimicrob. Chemother. 2001, 47:277-283.
33. Lee B.Y., Wiringa A.E., Bailey R.R., Lewis G.J., Feura J., Muder R.R. Staphylococcus aureus vaccine for orthopedic patients: an economic model and analysis. Vaccine 2010, 28:2465-2471.
34. Lelievre H., Lina G., Jones M.E., Olive C., Forey F., Roussel-Delvallez M., Nicolas-Chanoine M.H., Bebear C.M., Jarlier V., Andremont A., Vandenesch F., Etienne J. Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J. Clin. Microbiol. 1999, 37:3452-3457.
35. Li M., Cheung G.Y., Hu J., Wang D., Joo H.S., Deleo F.R., Otto M. Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains. J. Infect. Dis. 2010, 202:1866-1876.
36. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
37. Lowy F.D. Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 2003, 111:1265-1273.
38. Lozano C., Gomez-Sanz E., Benito D., Aspiroz C., Zarazaga M., Torres C. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains. Int. J. Med. Microbiol. 2011, 301:500-505.
39. Luzar M.A., Coles G.A., Faller B., Slingeneyer A., Dah G.D., Briat C., Wone C., Knefati Y., Kessler M., Peluso F. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N. Engl. J. Med. 1990, 322:505-509.
40. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., Zhang Q., Zhou J., Zurth K., Caugant D.A., Feavers I.M., Achtman M., Spratt B.G. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 1998, 95:3140-3145.
41. Malley R., Anderson P.W. Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc. Natl. Acad. Sci. USA 2012, 109:3623-3627.
42. Maree C.L., Daum R.S., Boyle-Vavra S., Matayoshi K., Miller L.G. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg. Infect. Dis. 2007, 13:236-242.
43. Mathews W.C., Caperna J.C., Barber R.E., Torriani F.J., Miller L.G., May S., Mccutchan J.A. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J. Acquir. Immune Defic. Syndr. 2005, 40:155-160.
44. Mccormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 2001, 55:77-104.
45. Mcdonald M., Dougall A., Holt D., Huygens F., Oppedisano F., Giffard P.M., Inman-Bamber J., Stephens A.J., Towers R., Carapetis J.R., Currie B.J. Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J. Clin. Microbiol. 2006, 44:3720-3727.
46. Mcdougal L.K., Steward C.D., Killgore G.E., Chaitram J.M., Mcallister S.K., Tenover F.C. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 2003, 41:5113-5120.
47. Melles D.C., Gorkink R.F., Boelens H.A., Snijders S.V., Peeters J.K., Moorhouse M.J., Van Der Spek P.J., Van Leeuwen W.B., Simons G., Verbrugh H.A., Van Belkum A. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J. Clin. Invest. 2004, 114:1732-1740.
48. Montgomery C.P., Boyle-Vavra S., Adem P.V., Lee J.C., Husain A.N., Clasen J., Daum R.S. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J. Infect. Dis. 2008, 198:561-570.
49. Montgomery C.P., Boyle-Vavra S., Daum R.S. Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One 2010, 5:e15177.
50. Naisbett J. High tech. High touch. John Naisbett's world view. Caring 2002, 21:24-27.
51. Nishifuji K., Sugai M., Amagai M. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J. Dermatol. Sci. 2008, 49:21-31.
52. Nubel U., Roumagnac P., Feldkamp M., Song J.H., Ko K.S., Huang Y.C., Coombs G., Ip M., Westh H., Skov R., Struelens M.J., Goering R.V., Strommenger B., Weller A., Witte W., Achtman M. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 2008, 105:14130-14135.
53. Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu. Rev. Microbiol. 2010, 64:143-162.
54. Patel M., Hoesley C.J., Moser S.A., Stamm A.M., Baddley J.W., Waites K.B. Dissemination of community-associated methicillin-resistant Staphylococcus aureus in a tertiary care hospital. South Med. J. 2008, 101:40-45.
55. Piechowicz L., Garbacz K., Wisniewska K., Dabrowska-Szponar M. Screening of Staphylococcus aureus nasal strains isolated from medical students for toxin genes. Folia Microbiol. (Praha) 2011, 56:225-229.
56. Proctor R.A. Challenges for a universal Staphylococcus aureus vaccine. Clin. Infect. Dis. 2012, 54:1179-1186.
57. Rasigade J.P., Laurent F., Lina G., Meugnier H., Bes M., Vandenesch F., Etienne J., Tristan A. Global distribution and evolution of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus, 1981-2007. J. Infect. Dis. 2010, 201:1589-1597.
58. Rouzic N., Janvier F., Libert N., Javouhey E., Lina G., Nizou J.Y., Pasquier P., Stamm D., Brinquin L., Pelletier C., Vandenesch F., Floret D., Etienne J., Gillet Y. Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genes. J. Clin. Microbiol. 2010, 48:1952-1955.
59. Schijffelen M.J., Boel C.H., Van Strijp J.A., Fluit A.C. Whole genome analysis of a livestock-associated methicillin-resistant Staphylococcus aureus ST398 isolate from a case of human endocarditis. BMC Genomics 2010, 11:376.
60. Schreiber J.R. Role of Toll like receptors in the antibody response to encapsulated bacteria. Front Biosci. (Elite Ed) 2012, 4:2638-2646.
61. Seale A., Finn A. What is the best way to use conjugate vaccines?. Curr. Opin. Infect. Dis. 2011, 24:219-224.
62. Sivaraman K., Venkataraman N., Cole A.M. Staphylococcus aureus nasal carriage and its contributing factors. Future Microbiol. 2009, 4:999-1008.
63. Tacconelli E., Carmeli Y., Aizer A., Ferreira G., Foreman M.G., D'agata E.M. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin. Infect. Dis. 2003, 37:1629-1638.
64. Tristan A., Bes M., Meugnier H., Lina G., Bozdogan B., Courvalin P., Reverdy M.E., Enright M.C., Vandenesch F., Etienne J. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg. Infect. Dis. 2007, 13:594-600.
65. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M.E., Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 2003, 9:978-984.
66. Verkaik N.J., Lebon A., De Vogel C.P., Hooijkaas H., Verbrugh H.A., Jaddoe V.W., Hofman A., Moll H.A., Van Belkum A., Van Wamel W.J. Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin. Microbiol. Infect. 2010, 16:1312-1317.
67. Von Eiff C., Becker K., Machka K., Stammer H., Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N. Engl. J. Med. 2001, 344:11-16.
68. Wang R., Braughton K.R., Kretschmer D., Bach T.H., Queck S.Y., Li M., Kennedy A.D., Dorward D.W., Klebanoff S.J., Peschel A., Deleo F.R., Otto M. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 2007, 13:1510-1514.
69. Wertheim H.F., Vos M.C., Ott A., Van Belkum A., Voss A., Kluytmans J.A., Van Keulen P.H., Vandenbroucke-Grauls C.M., Meester M.H., Verbrugh H.A. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004, 364:703-705.
70. Wiese L., Mejer N., Schonheyder H.C., Westh H., Jensen A.G., Larsen A.R., Skov R., Benfield T. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia. J. Infect. 2013, 67:199-205.
71. Wyllie D., Paul J., Crook D. Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control. J. Antimicrob. Chemother. 2011, 66:2685-2688.
72. Yanagisawa C., Hanaki H., Natae T., Sunakawa K. Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin. J. Infect. Chemother. 2007, 13:368-372.
73. Yang E.S., Tan J., Eells S., Rieg G., Tagudar G., Miller L.G. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin. Microbiol. Infect. 2010, 16:425-431.
74. Zielinska A.K., Beenken K.E., Joo H.S., Mrak L.N., Griffin L.M., Luong T.T., Lee C.Y., Otto M., Shaw L.N., Smeltzer M.S. Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J. Bacteriol. 2011, 193:2948-2958.